Steven H. Collis

CIK: 0001191508

Transaction Breakdown

Open Market Buys (P)2 (4.4%)

High conviction signal

Open Market Sales (S)14 (31.1%)

Position reduction

Option Exercises (M)15 (33.3%)

Derivative conversions

Awards (A)8 (17.8%)

Compensation grants

Other (G, F, J, C, D, …)6 (13.3%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (3)

BLCO

Bausch & Lomb Corp

Director

ELV

Elevance Health, Inc.

Director

COR

Cencora, Inc.

DirectorOfficer

Discretionary Trading P&L

Holdings

Transaction History (45 total)

BLCO
Bausch & Lomb Corp
May 26, 2026
Award(A)
Direct
15.8K shares at avg. $15.78$250K
ELV
Elevance Health, Inc.
May 13, 2026
Award(A)
Direct
563 shares-
BLCO
Bausch & Lomb Corp
Apr 30, 2026
Award(A)
Direct
1.4K shares at avg. $15.90$22K
ELV
Elevance Health, Inc.
Mar 5, 2026
Purchase(P)
Direct
3K shares at avg. $289.84$870K
BLCO
Bausch & Lomb Corp
Feb 23, 2026
Purchase(P)
Direct
15K shares at avg. $17.81$267K
BLCO
Bausch & Lomb Corp
Feb 23, 2026
Award(A)
Direct
4.5K shares-
BLCO
Bausch & Lomb Corp
Feb 19, 2026
Award(A)
Direct
5.3K shares-
COR
Cencora, Inc.
Sep 16, 2025
Exercise(M)
Direct
29.4K shares at avg. $86.09$2.5M
COR
Cencora, Inc.
Sep 16, 2025
Sale(S)
Direct
31.4K shares at avg. $289.86$9.1M
COR
Cencora, Inc.
Aug 19, 2025
Exercise(M)
Direct
12.6K shares at avg. $86.09$1.1M
COR
Cencora, Inc.
Aug 19, 2025
Sale(S)
Direct
14.6K shares at avg. $289.98$4.2M
ELV
Elevance Health, Inc.
Aug 1, 2025
Award(A)
Direct
639 shares-
COR
Cencora, Inc.
Jul 22, 2025
Exercise(M)
Direct
12.6K shares at avg. $86.09$1.1M
COR
Cencora, Inc.
Jul 22, 2025
Sale(S)
Direct
14.6K shares at avg. $292.67$4.3M
COR
Cencora, Inc.
Jun 24, 2025
Exercise(M)
Direct
12.6K shares at avg. $86.09$1.1M
COR
Cencora, Inc.
Jun 24, 2025
Sale(S)
Direct
14.6K shares at avg. $292.62$4.3M
COR
Cencora, Inc.
May 20, 2025
Exercise(M)
Direct
12.6K shares at avg. $86.09$1.1M
COR
Cencora, Inc.
May 20, 2025
Sale(S)
Direct
14.6K shares at avg. $293.84$4.3M
COR
Cencora, Inc.
Apr 22, 2025
Exercise(M)
Direct
12.6K shares at avg. $86.09$1.1M
COR
Cencora, Inc.
Apr 22, 2025
Sale(S)
Direct
14.6K shares at avg. $281.81$4.1M
COR
Cencora, Inc.
Mar 25, 2025
Sale(S)
Direct
2K shares at avg. $269.51$539K
COR
Cencora, Inc.
Mar 25, 2025
Sale(S)
Direct
12.6K shares at avg. $269.51$3.4M
COR
Cencora, Inc.
Mar 25, 2025
Exercise(M)
Direct
12.6K shares at avg. $86.09$1.1M
COR
Cencora, Inc.
Feb 27, 2025
Exercise(M)
Direct
12.6K shares at avg. $86.09$1.1M
COR
Cencora, Inc.
Feb 27, 2025
Sale(S)
Direct
2K shares at avg. $251.08$502K

		Type	Shares	Price		Ownership
May 26, 2026	BLCO Bausch & Lomb Corp	Award(A)	15,842	$15.78	$249,987	Direct
May 13, 2026	ELV Elevance Health, Inc.	Award(A)	563	-	$0	Direct
Apr 30, 2026	BLCO Bausch & Lomb Corp	Award(A)	1,415	$15.90	$22,499	Direct
Mar 5, 2026	ELV Elevance Health, Inc.	Purchase(P)	3,000	$289.84	$869,520	Direct
Feb 23, 2026	BLCO Bausch & Lomb Corp	Purchase(P)	15,000	$17.81	$267,150	Direct
Feb 23, 2026	BLCO Bausch & Lomb Corp	Award(A)	4,491	-	$0	Direct
Feb 19, 2026	BLCO Bausch & Lomb Corp	Award(A)	5,255	-	$0	Direct
Sep 16, 2025	COR Cencora, Inc.	Exercise(M)	29,350	$86.09	$2,526,742	Direct
Sep 16, 2025	COR Cencora, Inc.	Sale(S)	31,350	$289.86	$9,087,142	Direct
Aug 19, 2025	COR Cencora, Inc.	Exercise(M)	12,579	$86.09	$1,082,926	Direct
Aug 19, 2025	COR Cencora, Inc.	Sale(S)	14,579	$289.98	$4,227,618	Direct
Aug 1, 2025	ELV Elevance Health, Inc.	Award(A)	639	-	-	Direct
Jul 22, 2025	COR Cencora, Inc.	Exercise(M)	12,578	$86.09	$1,082,840	Direct
Jul 22, 2025	COR Cencora, Inc.	Sale(S)	14,578	$292.67	$4,266,543	Direct
Jun 24, 2025	COR Cencora, Inc.	Exercise(M)	12,579	$86.09	$1,082,926	Direct
Jun 24, 2025	COR Cencora, Inc.	Sale(S)	14,579	$292.62	$4,266,107	Direct
May 20, 2025	COR Cencora, Inc.	Exercise(M)	12,578	$86.09	$1,082,840	Direct
May 20, 2025	COR Cencora, Inc.	Sale(S)	14,578	$293.84	$4,283,600	Direct
Apr 22, 2025	COR Cencora, Inc.	Exercise(M)	12,579	$86.09	$1,082,926	Direct
Apr 22, 2025	COR Cencora, Inc.	Sale(S)	14,579	$281.81	$4,108,508	Direct
Mar 25, 2025	COR Cencora, Inc.	Sale(S)	2,000	$269.51	$539,020	Direct
Mar 25, 2025	COR Cencora, Inc.	Sale(S)	12,578	$269.51	$3,389,897	Direct
Mar 25, 2025	COR Cencora, Inc.	Exercise(M)	12,578	$86.09	$1,082,840	Direct
Feb 27, 2025	COR Cencora, Inc.	Exercise(M)	12,579	$86.09	$1,082,926	Direct
Feb 27, 2025	COR Cencora, Inc.	Sale(S)	2,000	$251.08	$502,160	Direct

1-25 of 45 transactions

About COLLIS STEVEN H

COLLIS STEVEN H (SEC CIK 0001191508) files insider reports with the SEC as Director of Bausch & Lomb Corp (BLCO), Director of Elevance Health, Inc. (ELV) and Executive Chairman of Cencora, Inc. (COR).

Signal8 holds 24 ownership filings by COLLIS STEVEN H (2 Form 3, 22 Form 4), filed between Sep 18, 2024 and May 28, 2026. Those filings report 45 transactions, from Sep 17, 2024 to May 26, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on COLLIS STEVEN H's filings is in INDIANAPOLIS, IN.

Recent filings by COLLIS STEVEN H

May 26, 2026: Grant or award of BLCO shares (Form 4, code A).
May 13, 2026: Grant or award of ELV shares (Form 4, code A).
Apr 30, 2026: Grant or award of BLCO shares (Form 4, code A).
Mar 5, 2026: Open-market purchase of ELV shares (Form 4, code P).
Feb 23, 2026: Open-market purchase of BLCO shares (Form 4, code P).

Other insiders filing for Bausch & Lomb Corp (BLCO)

Munsch Frederick, SVP, Controller and CAO
ROBERTSON RUSSEL C, Director
Paulson John, Director
Alfonso Eduardo, Director
Trebbi Barbara, Director
PAUL LAURENCE E, Director

How to read Form 4 transaction codes